Literature DB >> 18612440

Diagnostic accuracy of N-terminal pro-brain natriuretic peptide in the evaluation of postoperative left ventricular diastolic dysfunction.

Fatih Islamoglu1, Kaan Ozcan, Anil Z Apaydin, Cahide Soydas, Oya Bayindir, Isa Durmaz.   

Abstract

We compared the diagnostic accuracy of N-terminal prohormone brain natriuretic peptide (NT-proBNP) with that of echocardiography in the evaluation of left ventricular diastolic dysfunction after coronary artery bypass grafting. Thirty patients were studied prospectively. Patients who had recent myocardial infarction, unstable angina pectoris, or low ejection fraction with systolic dysfunction were excluded. Two blood samples were obtained: before anesthetic induction and on the 7th postoperative day. Levels of NT-proBNP were measured by electrochemiluminescence immunoassay. Comprehensive echocardiographic Doppler examinations were performed on admission and on the 7th postoperative day. Relationships between NT-proBNP levels and echocardiographic indices were evaluated by correlation, multiple linear regression, and receiver-operating characteristic curve analysis. There were significant and correlated worsenings in diastolic stage as determined both by echocardiographic indices and NT-proBNP levels. Early transmitral-to-early diastolic annular velocity ratio (E/Ea) was found to correlate with both NT-proBNP and postoperative diastolic functional stage (r=0.78, P <0.001). Mitral E/Ea was significantly more sensitive than were NT-proBNP levels in predicting diastolic functional stage. The area under the receiver-operating characteristic curve for NT-proBNP was significantly lower than that of mitral E/Ea (mean difference, 0.12; P=0.024). The NT-proBNP had 87.5% sensitivity and 55% specificity, whereas E/Ea had 87.5% sensitivity and 86.4% specificity. Plasma NT-proBNP levels are significantly related to mitral E/Ea ratio, which is a predictor of diastolic stage. Therefore, elevated NT-proBNP levels may indicate the time for a Doppler echocardiographic evaluation and identify a subgroup of patients at high risk who need closer monitoring during the early postoperative period.

Entities:  

Keywords:  Diastole/physiology; echocardiography; heart ventricles; left ventricular dysfunction; myocardial ischemia/diagnosis; natriuretic peptide, brain/blood/diagnostic use; predictive value of tests; pro-brain natriuretic peptide; sensitivity and specificity; ventricular dysfunction, left/blood/diagnosis/physiology

Mesh:

Substances:

Year:  2008        PMID: 18612440      PMCID: PMC2435446     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  24 in total

1.  The role of brain natriuretic peptide in the prediction of cardiac performance in coronary artery bypass grafting.

Authors:  Osman Saribulbul; Ilker Alat; Senol Coskun; Anil Z Apaydin; Tahir Yagdi; Mefkure Kiliccioglu; Emin Alp Alayunt
Journal:  Tex Heart Inst J       Date:  2003

2.  Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings.

Authors:  Emily Lubien; Anthony DeMaria; Padma Krishnaswamy; Paul Clopton; Jen Koon; Radmila Kazanegra; Nancy Gardetto; Erin Wanner; Alan S Maisel
Journal:  Circulation       Date:  2002-02-05       Impact factor: 29.690

3.  Coronary artery bypass grafting in patients with severe left ventricular dysfunction: predictive significance of left ventricular diastolic filling pattern.

Authors:  J Vaskelyte; N Stoskute; S Kinduris; E Ereminiene
Journal:  Eur J Echocardiogr       Date:  2001-03

4.  Changes in brain natriuretic peptide concentrations following open cardiac surgery with cardioplegic cardiac arrest.

Authors:  M S Avidan; N Meehan; J Ponte; A El-Gamel; R A Sherwood
Journal:  Clin Chim Acta       Date:  2001-01       Impact factor: 3.786

5.  Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.

Authors:  Mark Richards; M Gary Nicholls; Eric A Espiner; John G Lainchbury; Richard W Troughton; John Elliott; Christopher M Frampton; Ian G Crozier; Timothy G Yandle; Robert Doughty; Stephen MacMahon; Norman Sharpe
Journal:  J Am Coll Cardiol       Date:  2005-12-15       Impact factor: 24.094

6.  Comparative accuracy of B-type natriuretic peptide and tissue Doppler echocardiography in the diagnosis of congestive heart failure.

Authors:  Hisham Dokainish; William A Zoghbi; Nasser M Lakkis; Miguel A Quinones; Sherif F Nagueh
Journal:  Am J Cardiol       Date:  2004-05-01       Impact factor: 2.778

7.  Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function.

Authors:  Richard W Troughton; David L Prior; Jeremy J Pereira; Maureen Martin; Annette Fogarty; Annitta Morehead; Timothy G Yandle; A Mark Richards; Randall C Starling; James B Young; James D Thomas; Allan L Klein
Journal:  J Am Coll Cardiol       Date:  2004-02-04       Impact factor: 24.094

8.  Time course of human atrial natriuretic factor release during cardiopulmonary bypass in mitral valve and coronary artery diseased patients.

Authors:  S Curello; C Ceconi; F De Giuli; A Cargnoni; O Alfieri; A Pardini; P Marzollo; R Mastropiero; R Ferrari
Journal:  Eur J Cardiothorac Surg       Date:  1991       Impact factor: 4.191

9.  Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload.

Authors:  O Nakagawa; Y Ogawa; H Itoh; S Suga; Y Komatsu; I Kishimoto; K Nishino; T Yoshimasa; K Nakao
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

10.  Augmented secretion of brain natriuretic peptide in acute myocardial infarction.

Authors:  M Mukoyama; K Nakao; K Obata; M Jougasaki; M Yoshimura; E Morita; K Hosoda; S Suga; Y Ogawa; H Yasue
Journal:  Biochem Biophys Res Commun       Date:  1991-10-15       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.